We are excited to welcome Matthew Field, MD, PhD, MPH to Twin Cities Eye Consultants! Dr. Field is an accomplished physician-scientist with expertise in the fields of ophthalmology, genetics, and cancer biology. Dr. Field will bring expertise in ocular surface disease, cataracts, corneal transplants, secondary lens exchange, refractive surgery, oculoplastics, and anterior segment reconstruction, among other conditions.
Dr. Field completed his Bachelor of Arts degree in Sociology with Distinction at the University of North Carolina at Chapel Hill. He further honed his skills by earning a Master of Science in Health Policy & Management from the renowned Harvard T.H. Chan School of Public Health, where he received a tuition scholarship and distinguished himself as the class marshal.
Dr. Field later pursued an MD/PhD at The University of Miami, completing his PhD in Cancer Biology. His research focused on ocular oncology, conducting groundbreaking research at The Bascom Palmer Eye Institute, the number-one-rated ophthalmology program in the country. Dr. Field’s work led to the discovery of a biomarker for metastatic uveal melanoma, which is now utilized in the clinically available DecisionDx-UM test. His investigations into genetic mutations and evolutionary mechanisms in various ocular cancers have provided valuable insights into cancer progression and opened avenues for targeted treatments and are also included in clinically available diagnostic tests. His work was recognized with several research awards and grant funding from prestigious institutions such as the National Institutes of Health (NIH) and the Melanoma Research Foundation.
Dr. Field completed his internship and ophthalmology residency training at The University of Iowa, the second-ranked ophthalmology residency training program in the country. At Iowa, Dr. Field developed his passion for the cornea and anterior segment of the eye and helped discover a new pathogenic mechanism for Fuchs’ endothelial corneal dystrophy that is now being explored as a therapeutic target for medical management of the disease.
Dr. Field’s interest and dedication to advancing medical technology has led to the commercialization of a cutting-edge retinal imaging camera capable of detecting mitochondrial dysfunction. This state-of-the-art device enables the early detection of retinal diseases before irreversible cell loss occurs, revolutionizing the diagnostic capabilities in ophthalmology and allowing for timely interventions that can preserve vision and improve patient outcomes. Outside of work, Dr. Field loves spending time with his family, including his wife Sarah, son Merrick, and his puppy named River. Dr. Field grew up playing tennis, basketball, and soccer and continues to play tennis competitively.
